Amylin Commands Weight Loss Attention as Industry Anticipates Novo's Phase III CagriSema Readout BioSpace Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Semaglutide Cagrillintide Blended Peptides for Research & Clinical Trials Oraltide Pharma Switching from Semaglutide to Tirzepatide: Is It a Good Idea? Hubmed Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how